Related Experiment Video
Updated: May 10, 2026

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
Polymorphism of C3 complement in association with myocardial infarction in a sample of central Tunisia
Nadia Leban1, Karim Jraba, Abdelkader Chalghoum
1Biochemistry and Molecular Biology Laboratory, Faculty of Pharmacy, Street Avicenne, 5019 Monastir, Tunisia. lebannadia@yahoo.fr.
Insights
Genetic analysis revealed a significant association between the C3 complement polymorphism and myocardial infarction (MI). The C3*F allele strongly correlates with an increased risk of developing MI, highlighting its potential as a genetic marker for the disease.
Area of Science:
- Genetics
- Cardiovascular Medicine
- Immunology
Background:
- Myocardial infarction (MI) is a leading cause of mortality globally.
- Genetic factors play a crucial role in MI susceptibility.
- Understanding genetic markers for MI risk is vital for prevention and treatment.
Purpose of the Study:
- To investigate the correlation between the C3 complement polymorphism and myocardial infarction.
- To identify specific C3 alleles associated with increased MI risk.
Main Methods:
- A case-control study was conducted with 170 MI survivors and 95 healthy controls.
- C3 allele identification was performed using amplification refractory mutation system PCR.
- C3*S and C3*F alleles of the C3 polymorphism were analyzed.
Main Results:
- The frequency of C3*S and C3*F alleles in MI patients was 0.59 and 0.41, respectively.
- A significant increase in the C3*F allele was observed in MI patients (0.41) compared to controls (0.21).
- The C3*F allele showed a strong positive correlation with MI risk (odds ratio: 2.616).
Conclusions:
- A significant positive correlation exists between C3 polymorphism and myocardial infarction.
- The C3*F allele is associated with a substantially increased risk of MI.
- C3 polymorphism, particularly the C3*F allele, may serve as a valuable genetic marker for MI.
Background:
Myocardial infarction (MI) is a major clinical problem because of its large contribution to mortality. The genetic bases of this disease have been widely studied in recent years to find a clear association with some genetic markers that increase the risk of its occurrence. In the present investigation, the correlation between MI and the C3 complement polymorphism was analyzed using a case-control study.
Methods:
Our study ported on one hundred seventy survived myocardial infarction patients and ninety five healthy controls. The C3 allele identification was investigated using the amplification refractory mutation system PCR to determine the C3*S and the C3*F alleles of the C3 polymorphism.
Results:
Frequencies of C3*S and C3*F in patients are 0.59 and 0.41 respectively. Fisher test results showed a significant increase of C3*F allele in the sample of patients (0.41; odds ratio: 2.616; C.I [1.738-3.938]) compared to controls (0.21; odds ratio: 0.382; 95% CI [0.254-0.575]), p = 2.742 × 10-6.
Conclusion:
A strong positive correlation was found between C3 polymorphism and MI estimating that the risk of myocardial infarction is significantly increased among patients with C3*F allele of this polymorphism.
Virtual Slides:
The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1190484203893646.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome I: Introduction
Myocarditis I: Introduction

